Pivotal bioVenture Partners Investment Advisor LLC
Venture CapitalPosition in ARQT — Arcutis Biotherapeutics, Inc.
CIK 1844645
SAN FRANCISCO, CA
Position in ARQT
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$31,944,815
-$7,741,945 QoQ
Shares Held
1,355,892
-0.8% QoQ
Ownership
1.08%
of shares outstanding
% of Portfolio
11.42%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ARQT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Pivotal bioVenture Partners Investment Advisor LLC holds $268,178,415 across 11 Biotechnology names. ARQT ranks #4 (11.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PCVX |
Vaxcyte, Inc.
|
1,372,425 | $79,751,616 | |
| 2 | OCS |
Oculis Holding AG
|
1,680,283 | $44,678,724 | |
| 3 | EVMN |
Evommune, Inc.
|
1,926,943 | $44,300,419 | |
| 4 | ARQT |
Arcutis Biotherapeutics, Inc.
This page
|
1,355,892 | $31,944,815 | |
| 5 | TRVI |
Trevi Therapeutics, Inc.
|
1,553,726 | $18,535,951 | |
| 6 | IMNM |
Immunome Inc.
|
732,512 | $16,020,037 | |
| 7 | MPLT |
MapLight Therapeutics, Inc.
|
611,447 | $12,430,717 | |
| 8 | ZBIO |
Zenas BioPharma, Inc.
|
591,991 | $11,573,424 |
All Filings in ARQT
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $31,944,815 | 1,355,892 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $39,686,760 | 1,366,624 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $39,971,575 | 2,120,508 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $29,729,522 | 2,120,508 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $33,164,745 | 2,120,508 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $29,538,676 | 2,120,508 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $19,720,724 | 2,120,508 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $18,982,304 | 2,041,108 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $20,097,559 | 2,028,008 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $6,169,329 | 1,910,009 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $5,869,190 | 1,105,309 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $10,533,594 | 1,105,309 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $6,259,451 | 569,041 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $8,421,806 | 569,041 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $10,874,373 | 569,041 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $12,126,263 | 569,041 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $10,959,729 | 569,041 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $11,801,910 | 569,041 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $13,594,389 | 569,041 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $15,529,128 | 569,041 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $16,462,356 | 569,041 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $18,895,371 | 671,716 | Shares | Defined | 2021-02-09 | |
| No filing history on record for this holder in this stock. | ||||||